Wei-Chien Huang Selected Research

Wei-Chien Huang Research Topics

Disease

43	Neoplasms (Cancer) 03/2024 - 10/2004
18	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2007
12	Hepatocellular Carcinoma (Hepatoma) 02/2019 - 01/2012
9	Neoplasm Metastasis (Metastasis) 11/2022 - 04/2013
8	Lung Neoplasms (Lung Cancer) 11/2022 - 01/2011
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2011
6	Inflammation (Inflammations) 06/2023 - 09/2004
6	Infections 06/2023 - 01/2012
6	Triple Negative Breast Neoplasms 01/2021 - 01/2013
6	Carcinogenesis 01/2014 - 09/2004
4	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 09/2013
3	COVID-19 01/2022 - 01/2021
3	Oncogene Addiction 01/2018 - 11/2013
2	Experimental Arthritis 01/2022 - 01/2022
2	Rheumatoid Arthritis 01/2022 - 01/2022
2	Chronic Hepatitis B 01/2014 - 01/2012
1	Burns 01/2023
1	Macular Degeneration (Age-Related Maculopathy) 01/2023
1	Chondrosarcoma 01/2023
1	Lactic Acidosis 01/2022
1	Osteoarthritis 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Heart Arrest (Cardiac Arrest) 01/2021
1	Shock 01/2021
1	Coronavirus Infections 01/2021

Drug/Important Bio-Agent (IBA)

15	Tyrosine Kinase InhibitorsIBA 03/2024 - 01/2011
15	ErbB Receptors (EGF Receptor)IBA 01/2023 - 05/2008
14	Proteins (Proteins, Gene)FDA Link 06/2023 - 03/2009
11	Lapatinib (GW572016)FDA Link 03/2024 - 04/2013
6	Phosphotransferases (Kinase)IBA 01/2021 - 05/2008
6	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 05/2008
6	NF-kappa B (NF-kB)IBA 11/2013 - 10/2004
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 08/2007
4	SmokeIBA 11/2022 - 11/2017
4	human ERBB2 proteinIBA 10/2021 - 04/2013
4	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 06/2011
3	MelatoninIBA 01/2023 - 02/2019
3	Small Interfering RNA (siRNA)IBA 02/2019 - 01/2014
3	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 01/2019 - 03/2011
3	hepatitis B virus X proteinIBA 01/2016 - 01/2012
3	Gefitinib (Iressa)FDA Link 09/2013 - 01/2011
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 06/2011 - 05/2008
2	7-hydroxycoumarin (umbelliferone)IBA 03/2024 - 06/2023
2	Serine Proteases (Serine Protease)IBA 03/2024 - 01/2021
2	Serine (L-Serine)FDA Link 01/2023 - 01/2018
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 01/2017
2	Peptides (Polypeptides)IBA 02/2022 - 01/2013
2	CytokinesIBA 01/2022 - 01/2022
2	antcin KIBA 01/2022 - 01/2022
2	Estrogen ReceptorsIBA 03/2021 - 11/2013
2	Proteasome InhibitorsIBA 09/2019 - 11/2013
2	Sodium-Glucose Transporter 1IBA 01/2019 - 05/2008
2	Conditioned Culture MediaIBA 01/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 09/2016 - 11/2015
2	SERPIN-B5 (maspin)IBA 08/2016 - 09/2015
2	MicroRNAs (MicroRNA)IBA 09/2015 - 05/2013
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2014 - 09/2013
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2014
2	Polysaccharides (Glycans)IBA 01/2014 - 01/2012
2	Tyrosine (L-Tyrosine)FDA Link 09/2013 - 01/2013
2	SodiumIBA 09/2013 - 01/2013
2	SymportersIBA 09/2013 - 01/2013
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2004 - 09/2004
1	Peptide Hydrolases (Proteases)FDA Link 03/2024
1	eriodictyolIBA 03/2024
1	Glutamine (L-Glutamine)FDA Link 01/2023
1	AmphiregulinIBA 01/2023
1	erucylphosphocholineIBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Alanine (L-Alanine)FDA Link 01/2023
1	AlkaliesIBA 01/2023
1	NADP (NADPH)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	LigandsIBA 01/2023
1	Cysteine (L-Cysteine)FDA Link 01/2023
1	GlutaminaseIBA 01/2023
1	IntegrinsIBA 11/2022
1	pyreneIBA 11/2022
1	OsteopontinIBA 11/2022
1	GC376IBA 05/2022
1	Fast GreenIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	safranine T (safranin)IBA 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	Protein Kinase CIBA 01/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 09/2021
1	HesperidinIBA 08/2021
1	Pemetrexed (MTA)FDA Link 03/2021
1	hamamelitanninIBA 03/2021
1	AminopterinIBA 03/2021
1	camostatIBA 01/2021
1	nafamostatIBA 01/2021

Therapy/Procedure

11	Therapeutics 03/2024 - 05/2008
1	Oral Administration 06/2023
1	Neoadjuvant Therapy 09/2021